Assai plans 100 pharmacies by 2027: what it means for Assai stock

Published on 10/21/2026 at 07:23 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Assai plans 100 pharmacies in 2027, with 25 units targeted by December. Assai stock saw Q2 profit rise 93.6 percent to BRL 344 million.

Operating plans and reporting dates

Assai planned 100 pharmacies for 2027 in a report dated October 15, 2026.
Second-quarter 2026 net revenue reached BRL 19.2 billion.
Assai scheduled its third-quarter 2026 earnings release for November 5, 2026.

Assai, BRASAIACNOR0, Illustration mit AI erstellt.

Assai (BRASAIACNOR0) plans to add 100 in-store pharmacies in 2027, while targeting 25 locations by December, El Fondo reported on October 15, 2026. The expansion shifts attention toward extracting more revenue from the existing store base rather than opening stores at a faster pace.

Three recent milestones

On October 13, 2026, Bank of America raised its Assai price target from BRL 12.00 to BRL 17.00 while reiterating its recommendation, according to InfoMoney. On October 14, 2026, Assai said it had no decision or ongoing study for a primary share offering, Estadao reported. The pharmacy plan followed on October 15, 2026, with nine units already operating and 25 targeted by December.

What does pharmacy expansion mean?

The initiative uses existing store traffic and shared operating costs, making the revenue opportunity less dependent on new locations. The company also plans to prioritize returns from its current network while debt remains a central constraint.

Assai's second-quarter 2026 revenue was BRL 19.2 billion, up 0.9 percent, while recurring net profit rose 93.6 percent to BRL 344 million. Adjusted EBITDA fell 0.7 percent to BRL 1.1 billion, with a 5.6 percent margin, according to El Fondo. Net debt declined by BRL 1.4 billion over twelve months to June 2026, and leverage fell to 2.37 times from 3.17 times a year earlier.

Dates investors can mark

Assai's investor-relations calendar lists November 5, 2026, for the third-quarter 2026 earnings release and November 6, 2026, for the conference call, according to the company's Assai.

Market context for Assai

ASAI3 was last at BRL 13.98 on October 20, 2026, at 9:31 p.m. BRT on B3. The share had a 52-week range of BRL 6.91 to BRL 14.14 and a market capitalization of BRL 18.7 billion as of October 20, 2026. The price sits near the upper end of that range, leaving execution of the pharmacy rollout and progress on leverage as the clearest measurable tests for the next report.